Toggle navigation
Home
Search
Services
Blog
Contact
About
Develop Monoclonal Antibodies of Tumor Growth
Kim, Jungsuh
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 3 grants from Jungsuh Kim
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of Novel Therapeutic Anti-Tau Antibodies
The Role of B-Cell Receptor and NF<B in Germinal Center B-Cell Lymphomas
Structure/Function Studies on Flavoproteins
Translational Research & Mentoring in Cutaneous Lymphoma
Molecular Characterization of A Novel Human Cyclin
Recently added grants:
Epigenetics of uterine quiescence
Multivalent DNA vaccine-mediated protection against Tuberculosis
Host Genes Critical for Flavivirus Infection
The integrated stress response in stem cells and cancer
ST8Sia6 expression on tumors inhibits the immune response
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057763-000
Application #
3613354
Study Section
Project Start
1985-09-16
Project End
Budget Start
1985-09-16
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Comments
Be the first to comment on Jungsuh Kim's grant